Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Scorpion Therapeutics logo

Scorpion Therapeutics

Recent Finacing

Series C

Recent Raise

$150M

Scorpion Therapeutics is a clinical-stage oncology company developing selective small-molecule precision medicines via an integrated platform of cancer biology, medicinal chemistry, translational medicine, and data science; programs include STX-478.

Founded 2020
Massachusetts, United States
11-50
Private
scorpiontx.com

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Oncology
Precision Medicine

Recent Investors

Abingworth logo
Atlas Venture logo
Vida Ventures logo
Omega Funds logo
EcoR1 Capital logo
Invus logo
Surveyor Capital logo
OrbiMed logo
Wellington Management logo
Logos Capital logo
Casdin Capital logo
Woodline Partners logo

Financials

$420M

Total Raised

3

Funding rounds

20

Investors


Team

Upgrade to view the team

See the team members at Scorpion Therapeutics.